Unibail-Rodamco-Westfield: A cap raise, new strategy, the situation has changed

Avatar Russell Katz, April 6, 2022

Unibail-Rodamco-Westfield (ASX: URW) | Stocks Down Under

19 October 2020

A lot has changed for URW since our first publication on 18 August. The stock had fallen 19.7% prior to Friday, 16 October 2020’s market open due to shareholders rejecting management’s massive dilution and balance sheet revamp plan. In fact, after a group of shareholders, representing 4.1% ownership in URW, released a different plan of action the market responded by driving URW’s share price up approximately 12.1% on 16 October 2020. However, management has already met and released a statement strongly opposing the plan put forward by this shareholder group and the truth is, 4.1% is just not a large enough block of shares to force management to back down. For this group’s plan to be pushed past management, we believe shareholders representing at least double this block’s equity stake would be required to join forces with them publicly. Therefore, the question must be asked, if management’s plan is enacted, and the massive dilution does occur, do we keep our four star rating?

The answer to that is yes, and here’s why. First of all, the full amount of the capital raisings and asset sales will be used to pay down URW’s €7.8bn debt maturing in 2HY22. This would reduce URW’s total debt by well over half and leave the company in an extremely strong financial position. Second of all, based on the current share price, even after the dilution, the company would still be trading at an unreasonable discount to its asset value.

A €3.5bn capital raise, assuming a 30% discount to 16 October 2020’s closing price, would mean the issuing of around 121,300,340 new shares; a dilution of about 46.7%. As of 30 June 2020, EPRA Net Reinstatement Value (NRV) was around €27.3bn. Subtracting the €4bn worth of assets to be sold gives us a per share value, after dilution, of approximately €89.6, or €4.5 per CDI (20-1 CDI ratio). Using the Euro / Australian Dollar exchange rate as of 16 October 2020, that comes to a EPRA NRV of about $7.44 per CDI; 122.8% higher than 16 October 2020’s close.

The truth is, no matter whose plan is followed, we believe URW is still heavily undervalued.


Want to become a better investor. Let us help you!


Get our 4 publications per week on ASX-listed

large, mid and small cap companies across all sectors

Model portfolios

Investor Webinars


Get access to all editions through a 30-day FREE TRIAL.

No credit card required!


Recent Posts


What is an asset impairment? And is it really that bad a kick in the guts as some investors think?

You may have heard companies announce an impairment of particular assets. This is typically perceived by investors as bad news,…


The FIRB … Who is the Foreign Investment Review Board and why do they kill great deals?

Investors may or may not know the Foreign Investment Review Board (FIRB), but those who do might know it for…

high interest rates impact tech stocks

How exactly do high interest rates impact tech stocks? Here are 6 ways

We all know high interest rates impact tech stocks. But while most investors would know that fact, not all investors…